HUN Stock Analysis: Huntsman | NYSE
Chemicals | NYSE, USA | Market Cap: 1.612m USD | 12M Return: -9% | US4470111075 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.4M
Qual. Beats: -1
Rev. Trend: -82.8%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Huntsman Corporation (NYSE: HUN) is a global manufacturer of diversified organic chemical products operating through three segments: Polyurethanes, Performance Products, and Advanced Materials. Founded in 1970 and headquartered in The Woodlands, Texas, the company went public in February 2005 and is classified within the GICS Materials sector under the Diversified Chemicals sub-industry, with a mid-cap market capitalization of approximately $2.1 billion.
The Polyurethanes segment produces MDI, polyols, thermoplastic polyurethane, and related co-products such as aniline and benzene. The Performance Products segment focuses on amines and catalysts, while the Advanced Materials segment supplies epoxy, phenoxy, acrylic, polyurethane, and acrylonitrile-butadiene-based polymer formulations. Together, the portfolio serves a broad set of end markets, including automotive, aerospace, construction, electronics, packaging, oil and gas, footwear, furniture, power generation, and medical appliances. Huntsman distributes its products globally through a network of third-party distributors and agents, supplementing this with pre- and post-sales technical service support for customers.
As a diversified chemicals producer, Huntsmans revenue and margins are typically exposed to the cyclical pricing of commodity feedstocks and downstream chemical demand, particularly within housing, automotive, and industrial end markets. The companys segment structure reflects a balance between higher-volume polyurethane commodity chemicals and higher-margin specialty formulations used in adhesives, coatings, and electronics.
- MDI oversupply pressures polyurethane selling prices globally
- Aerospace recovery boosts Advanced Materials volumes and margins
- European industrial demand softness weighs on overall volumes
| Net Income: -171.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -2.00 > 1.0 |
| NWC/Revenue: 9.48% < 20% (prev 11.33%; Δ -1.85% < -1%) |
| CFO/TA 0.02 > 3% & CFO 159.0m > Net Income -171.0m |
| Net Debt (2.57b) to EBITDA (281.0m): 9.14 < 3 |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (173.0m) vs 12m ago 0.23% < -2% |
| Gross Margin: 13.50% > 18% (prev 13.74%; Δ -0.24% > 0.5%) |
| Asset Turnover: 82.28% > 50% (prev 81.99%; Δ 0.28% > 0%) |
| Interest Coverage Ratio: -0.18 > 6 (EBIT TTM -15.0m / Interest Expense TTM 83.0m) |
| A: 0.08 (Total Current Assets 2.28b - Total Current Liabilities 1.72b) / Total Assets 7.19b |
| B: 0.24 (Retained Earnings 1.72b / Total Assets 7.19b) |
| C: -0.00 (EBIT TTM -15.0m / Avg Total Assets 7.17b) |
| D: 0.63 (Book Value of Equity 2.69b / Total Liabilities 4.26b) |
| Altman-Z'' = 1.94 = BBB |
| DSRI: 1.08 (Receivables 880.0m/813.0m, Revenue 5.90b/5.86b) |
| GMI: 1.02 (GM 13.74% / 13.50%) |
| AQI: 1.01 (AQ_t 0.29 / AQ_t-1 0.29) |
| SGI: 1.01 (Revenue 5.90b / 5.86b) |
| TATA: -0.05 (NI -171.0m - CFO 159.0m) / TA 7.19b) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of September 20, 2026, the stock is trading at USD 9.09 with a total of 3,668,664 shares traded. Over the past week, the price has changed by -3.81%, over one month by -8.69%, over three months by -23.97% and over the past year by -8.96%.
Current recommended Stop Loss: 8.60 (which is 5.4% or 1.4 ATR below the current price).
Huntsman has received a consensus analysts rating of 3.13. Therefore, it is recommended to hold HUN.
- StrongBuy: 1
- Buy: 1
- Hold: 12
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 11.6 | 27.8% |
P/E Forward = 54.3478
P/S = 0.2733
P/B = 0.6007
P/EG = 2.2202
Revenue TTM = 5.90b USD
EBIT TTM = -15.0m USD
EBITDA TTM = 281.0m USD
Long Term Debt = 1.72b USD (from longTermDebt, last quarter)
Short Term Debt = 419.0m USD (from shortTermDebt, last quarter)
Debt = 2.92b USD (from shortLongTermDebtTotal, last quarter) + Leases 414.0m
Net Debt = 2.57b USD (calculated: Debt 2.92b - CCE 346.0m)
Enterprise Value = 4.18b USD (1.61b + Debt 2.92b - CCE 346.0m)
Interest Coverage Ratio = -0.18 (Ebit TTM -15.0m / Interest Expense TTM 83.0m)
EV/FCF = -464.5x (Enterprise Value 4.18b / FCF TTM -9.00m)
FCF Yield = -0.22% (FCF TTM -9.00m / Enterprise Value 4.18b)
FCF Margin = -0.15% (FCF TTM -9.00m / Revenue TTM 5.90b)
Net Margin = -2.90% (Net Income TTM -171.0m / Revenue TTM 5.90b)
Gross Margin = 13.50% ((Revenue TTM 5.90b - Cost of Revenue TTM 5.10b) / Revenue TTM)
Gross Margin QoQ = 14.73% (prev 12.89%)
Tobins Q-Ratio = 0.58 (Enterprise Value 4.18b / Total Assets 7.19b)
Interest Expense / Debt = 2.85% (Interest Expense 83.0m / Debt 2.92b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -11.8m (EBIT -15.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.33 (Total Current Assets 2.28b / Total Current Liabilities 1.72b)
Debt / Equity = 1.08 (Debt 2.92b / totalStockholderEquity, last quarter 2.69b)
Debt / EBITDA = 9.14 (Net Debt 2.57b / EBITDA 281.0m)
Debt / FCF = -285.4 (out of range, set to none) (Net Debt 2.57b / FCF TTM -9.00m)
Total Stockholder Equity = 2.72b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.39% (Net Income -171.0m / Total Assets 7.19b)
RoE = -6.28% (Net Income TTM -171.0m / Total Stockholder Equity 2.72b)
RoCE = -0.34% (EBIT -15.0m / Capital Employed (Equity 2.72b + L.T.Debt 1.72b))
RoIC = -0.21% (negative operating profit) (NOPAT -11.8m / Invested Capital 5.60b)
WACC = 4.81% (E(1.61b)/V(4.53b) * Re(9.45%) + D(2.92b)/V(4.53b) * Rd(2.85%) * (1-Tc(0.21)))
Discount Rate = 9.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 78.52 | Cagr: 0.31%
[DCF] Fair Price = unknown (Cash Flow -9.00m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -2.16 | # QB: -1
Revenue Correlation: -82.83 | Revenue CAGR: -2.81% | SUE: 1.51 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.07 | Chg30d=+2.03% | Revisions=-36% | Analysts=13
EPS current Year (2026-12-31): EPS=-0.23 | Chg30d=+0.73% | Revisions=-50% | GrowthEPS=+67.1% | GrowthRev=+8.6%
EPS next Year (2027-12-31): EPS=0.20 | Chg30d=-3.29% | Revisions=-8% | GrowthEPS=+188.1% | GrowthRev=+2.2%
[Analyst] Revisions Ratio: -38% (up=9, down=22)